Carpal tunnel syndrome. Carpal tunnel syndrome, unspecified upper limb
Conditions
Interventions
Intervention 1: Intervention group: Patients receiving Rosuvastatin 40 mg. Intervention 2: Control group: receiving a placebo drug.
Sponsors
Qazvin University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: People who, in terms of clinical symptoms, have suspicious symptoms related to carpal tunnel syndrome (including pain, paresthesia, and numbness in the area of ??the median nerve) People whose CTS is confirmed by electrodiagnostic tests.
Exclusion criteria
Exclusion criteria: - Subjects should not be treated with any drug from the statin group. ??people with hypothyroidism people with connective tissue diseases people with rheumatoid arthritis people with malignancy including Lipoma/ hemangioma / people with infectious and inflammatory diseases including sarcoidosis/ septic arthritis any trauma and local bleeding hemodialysis/ pregnancy/ any conditions that cause edema and increase in total body fluid people with cts with grade severe refers to this group in terms of clinical symptoms of people who have hypotrophy and atrophy of the thenar muscle or people who were classified as grade/severe based on electrodiagnostic tests
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of carpal tunnel disease. Timepoint: Start of the study/three months after the start of the study. Method of measurement: Electrodiagnostic tests/questionnaire.;AMPLITUDE of Median nerve. Timepoint: Start of the study/three months after the start of the study. Method of measurement: Electrodiagnostic tests/questionnaire.;LATENCY of Median nerve. Timepoint: Start of the study/three months after the start of the study. Method of measurement: Electrodiagnostic tests/questionnaire.;BMI. Timepoint: Start of the study. Method of measurement: questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction of clinical symptoms of patients including paresthesia and pain and. Timepoint: Beginning of the study/ three months after the beginning of the study. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFarnaz Alidaee
Qazvin University of Medical Sciences
Outcome results
None listed